Primary GBM is routinely associated with mutation of PTEN (Ohgaki et al., 2004), EGFR amplification (Ekstrand et al., 1992), and p16INK4a deletion (Biernat et al., 1997). This evidence concerns the gene CDKN2A and glioblastoma.